ASBP Bulls Back In Control After 78% Crash: What Changed?

• Aspire Biopharma also secured a commitment for a $22.5 million credit facility to help fund its planned acquisition of Dura Control Systems.
• The deal is not expected to require any additional equity raise, the company said.
• Aspire’s unit, Buzz Bomb Caffeine Company, recently partnered with Interwest Brokerage to expand its retail presence in the Intermountain West.

Aspire Biopharma Holdings (ASBP) grabbed retail traders’ attention Tuesday after its shares surged more than 20% in pre-market trading, following the successful close of a $21 million private placement that lifted its shareholders’ equity above Nasdaq’s minimum listing requirement.

ASBP shares are poised to bounce back after four straight sessions of losses that saw it plunge more than 78% and fall to a 52-week low on Monday.

The company also secured a commitment for a $22.5 million credit facility to help fund its planned acquisition of Dura Control Systems (DCS). The deal is not expected to require any additional equity raise, Aspire Biopharma added.

How Did Retail Traders React?

Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier. Message volumes on the platform surged 1,175% over a 24-hour period and a whopping 5,000% over a seven-day period.

One user expects the stock to reclaim $1. It last traded above that on April 14.

Another user expects range-bound trading.

Beyond Drug Delivery

Last week, Aspire Biopharma signed a letter of intent to acquire DCS in an all-cash deal valued at $30 million. DCS is a global automotive supplier with over $200 million in FY2025 revenue and more than $20 million in earnings before interest, tax, depreciation, and amortization (EBITDA).

DCS holds a broad portfolio of parts and patents serving major automakers. Aspire said the acquisition would help it evolve into a diversified, high-revenue business beyond its core drug delivery technology.

Prior to that, Aspire’s unit, Buzz Bomb Caffeine Company, partnered with Interwest Brokerage to expand its retail presence in the Intermountain West. The unit’s Buzz Bomb is a single-serve caffeine powder taken under the tongue that delivers 50 mg of caffeine, eliminating the need for drinks like coffee or energy beverages.

Year-to-date, the stock has slumped more than 93%.

For updates and corrections, email newsroom[at]stocktwits[dot]com.